Literature DB >> 26528

Dihydropyrimidinase. Metabolism of some cyclic imides of different ring size.

J H Maguire, K H Dudley.   

Abstract

The ability of dihydropyrimidinase (EC 3.5.2.2) to hydrolyze cyclic imides of different ring size was investigated. Succinimide, glutarimide, and adipimide are five-, six-, and seven-membered cyclic imides, respectively. The ring-opened compounds that correspond to these cyclic imides are, respectively, succinamic, glutaramic, and adipamic acid. In incubations of cyclic imides (pH 8, 1 hr) with a rat liver dihydropyrimidinase preparation from which omega-amidase had been removed, adipimide was classed as a good substrate and succinimide and glutarimide were classed as very poor but definite substrates. alpha-Phenylsuccinimide, the N-demethylated metabolite of phensuximide, was a much better substrate than succinimide. alpha-Phenylglutarimide was not a substrate. The in vitro studies of the present investigation were in agreement with observations made in previous in vivo studies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26528

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  A novel amidase (half-amidase) for half-amide hydrolysis involved in the bacterial metabolism of cyclic imides.

Authors:  C L Soong; J Ogawa; S Shimizu
Journal:  Appl Environ Microbiol       Date:  2000-05       Impact factor: 4.792

2.  Cyclic-imide-hydrolyzing activity of D-hydantoinase from Blastobacter sp. strain A17p-4.

Authors:  C L Soong; J Ogawa; M Honda; S Shimizu
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

3.  Novel Metabolic Transformation Pathway for Cyclic Imides in Blastobacter sp. Strain A17p-4.

Authors:  J Ogawa; C L Soong; M Honda; S Shimizu
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

4.  2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis.

Authors:  Adam D Kennedy; Kirk L Pappan; Taraka Donti; Mauricio R Delgado; Marwan Shinawi; Toni S Pearson; Seema R Lalani; William E Craigen; V Reid Sutton; Anne M Evans; Qin Sun; Lisa T Emrick; Sarah H Elsea
Journal:  Front Neurosci       Date:  2019-05-08       Impact factor: 4.677

5.  Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis.

Authors:  Adam D Kennedy; Kirk L Pappan; Taraka Donti; Mauricio R Delgado; Marwan Shinawi; Toni S Pearson; Seema R Lalani; William J Craigen; V Reid Sutton; Anne M Evans; Qin Sun; Lisa T Emrick; Sarah H Elsea
Journal:  Front Neurosci       Date:  2020-01-29       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.